GO:0015204 urea transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015204 (urea transmembrane transporter activity) enables the transfer of urea across biological membranes, a process essential for nitrogen disposal and osmotic balance.
• Urea transporters are members of the SLC14A family (UT-A and UT-B) and are structurally related to aquaporins, forming channels that facilitate urea permeation.
• UT-B (SLC14A1) is a major facilitator of urea transport in erythrocytes and kidney, and its dysfunction is linked to diseases such as melanoma and kidney disorders.
• Small-molecule inhibitors of urea transporters, such as phenylphthalazines, have been developed and their binding models elucidated, offering pharmacological tools.
• Urea transport is also mediated by other transporters like SLC6A18, which functions as a Na-dependent glycine/urea antiporter in the proximal straight tubule.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the physiological roles of urea transporters in health and disease.
Description
Urea transmembrane transporter activity (GO:0015204) is a molecular function that enables the movement of urea across cell membranes. Urea is a small, water-soluble molecule that serves as the primary nitrogenous waste product in mammals, and its transport is critical for maintaining nitrogen balance and osmotic homeostasis. This activity is mediated by specialized membrane proteins, including the SLC14A family of urea transporters (UT-A and UT-B), which form channels that facilitate urea permeation. Researchers study this term to understand how cells regulate urea flux, how defects in urea transport contribute to disease, and how these transporters can be targeted therapeutically. The importance of urea transport extends beyond the kidney; it plays roles in the urinary concentrating mechanism, erythrocyte function, and even cancer biology. Given its broad physiological relevance, GO:0015204 is a key focus in nephrology, hematology, and oncology research.
urea transmembrane transporter activity At A Glance
| GO ID | GO:0015204 |
|---|---|
| GO term | urea transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | urea transporter activity |
| Major function | Enables the transfer of urea across membranes |
| Major gene families | SLC14A (UT-A, UT-B), SLC6A18 |
| Related diseases | Melanoma, kidney disorders, osmotic imbalance |
| Research methods | CRISPR knockout, knock-in, overexpression, transport assays |
What Is GO:0015204?
According to the Gene Ontology, GO:0015204 (urea transmembrane transporter activity) is defined as the molecular function that enables the transfer of urea from one side of a membrane to the other. Urea is the water-soluble compound H2N-CO-NH2. This activity is typically carried out by integral membrane proteins that form channels or carriers, allowing urea to cross lipid bilayers down its concentration gradient or via facilitated diffusion.
Why Is urea transmembrane transporter activity Important in Cell Biology?
Urea transmembrane transporter activity is fundamental to nitrogen metabolism and osmotic regulation in mammals. It facilitates the excretion of urea, a major nitrogenous waste, and contributes to the urinary concentrating mechanism by allowing urea recycling in the kidney. Beyond the kidney, urea transporters are expressed in erythrocytes, the cornea, and various tissues, where they influence cell volume and solute balance. Dysregulation of urea transport has been implicated in diseases such as melanoma, where UT-B downregulates polyamines and activates p53, and in kidney disorders linked to mutations in SLC14A1. Understanding this activity is therefore crucial for developing therapeutic strategies targeting urea transporters.
• Urea transport is essential for nitrogen disposal and osmotic balance in mammals.
• UT-B (SLC14A1) is a major urea transporter in erythrocytes and kidney, affecting urine concentration.
• UT-B downregulates polyamines in melanoma cells via p53 activation, linking urea transport to cancer biology.
• SLC6A18 functions as a Na-dependent glycine/urea antiporter in the proximal straight tubule, influencing glomerular filtration rate.
• Urea transporters are expressed in non-renal tissues such as corneal endothelial cells, where they mediate water and urea transport.
• Small-molecule inhibitors of UT-B, such as phenylphthalazines, provide pharmacological tools to study urea transport.
• Mutations in SLC14A1 can cause kidney disorders and affect blood pressure regulation.
• Urea transport is a potential therapeutic target in cancer and kidney diseases.
• CRISPR-based models enable precise dissection of urea transporter functions in vivo.
• Urea transporters are structurally related to aquaporins, offering insights into membrane channel evolution.
What Happens During urea transmembrane transporter activity?
Urea Binding and Channel Gating
In simple terms: Urea binds to a specific site in the transporter, which opens a channel through the membrane.
Urea transporters, such as UT-B, form channels that facilitate urea permeation. Structural studies reveal that urea binds within a central pore, and conformational changes allow its passage across the membrane. The binding site involves conserved residues that coordinate urea, and the channel is gated by structural elements that regulate permeability.
Urea Permeation and Transport
In simple terms: Urea moves through the channel from one side of the membrane to the other.
Once bound, urea is transported through the channel down its concentration gradient. This process is passive and does not require ATP, although it can be regulated by phosphorylation and other post-translational modifications. The rate of transport is influenced by the expression level of the transporter and the membrane composition.
Regulation by Inhibitors and Modulators
In simple terms: Certain molecules can block or slow down urea transport by binding to the transporter.
Small-molecule inhibitors, such as phenylphthalazines, bind to UT-B and inhibit urea transport. Their binding models have been elucidated, showing that they occupy the urea permeation pathway and prevent urea passage. These inhibitors are valuable for studying urea transport physiology and as potential therapeutics.
Physiological Roles in Kidney and Beyond
In simple terms: Urea transport helps the kidney concentrate urine and maintains water balance in other tissues.
In the kidney, urea transporters facilitate urea recycling, which is essential for the urinary concentrating mechanism. In the proximal straight tubule, SLC6A18 mediates urea secretion, influencing glomerular filtration rate. In corneal endothelial cells, urea transporters contribute to water and urea transport, maintaining corneal transparency.
Key Genes Involved in GO:0015204 urea transmembrane transporter activity
The following genes encode proteins that exhibit urea transmembrane transporter activity or are directly involved in urea transport across membranes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC14A1 | Encodes UT-B, a urea transporter in erythrocytes and kidney | Mutations cause kidney disorders; target for inhibitors |
| SLC14A2 | Encodes UT-A isoforms, involved in kidney urea recycling | Regulates urine concentration; studied in knockout models |
| SLC6A18 | Na-dependent glycine/urea antiporter in proximal straight tubule | Influences glomerular filtration rate; linked to hypertension |
| SLC7A1 | Arginine transporter, indirectly affects urea cycle | KRAS-induced arginine auxotrophy in lung cancer |
| RHAG | Rh-associated glycoprotein, interacts with UT-B | Required for UT-B trafficking in erythrocytes |
| RHCE | Rh blood group antigen, may interact with urea transporters | Potential role in erythrocyte urea transport |
| AQP1 | Aquaporin-1, facilitates water and urea transport | Co-expressed with urea transporters in kidney |
| AQP3 | Aquaporin-3, transports water and urea | Involved in skin and kidney urea transport |
| UT-B | Urea transporter B (protein product of SLC14A1) | Target for small-molecule inhibitors |
| UT-A1 | Urea transporter A1 (protein product of SLC14A2) | Regulated by vasopressin in kidney |
| UT-A2 | Urea transporter A2 (protein product of SLC14A2) | Mediates urea reabsorption in thin descending limb |
| UT-A3 | Urea transporter A3 (protein product of SLC14A2) | Facilitates urea secretion in inner medullary collecting duct |
| p53 | Tumor suppressor, activated by UT-B downregulation | Mediates polyamine downregulation in melanoma |
| NFκB | Transcription factor activated by RhBG | Downstream signaling of ammonia transporter |
| RhBG | Ammonia transporter, may interact with urea transporters | Activates NFκB signaling |
| SLC14A1 variants | Polymorphisms affecting urea transport | Associated with blood pressure and kidney function |
How Is urea transmembrane transporter activity Regulated?
Urea transporter activity is regulated at multiple levels. Transcriptional regulation of SLC14A1 and SLC14A2 is influenced by osmotic stress and vasopressin. Post-translational modifications, such as phosphorylation, can modulate transporter trafficking and activity. In melanoma cells, UT-B downregulation leads to p53 activation and reduced polyamine levels, indicating a regulatory link between urea transport and tumor suppressor pathways. Additionally, small-molecule inhibitors like phenylphthalazines can acutely inhibit UT-B activity, providing a means to regulate urea transport pharmacologically.
urea transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC14A1 | Kidney disorders, blood pressure regulation | Knockout mouse, knock-in of patient mutations |
| SLC14A2 | Nephrogenic diabetes insipidus | Kidney-specific knockout, overexpression |
| SLC6A18 | Hypertension, glomerular filtration rate | Knockout rat, point mutation |
| SLC14A1 (UT-B) | Melanoma progression | Overexpression in melanoma cell lines, knockout |
| SLC7A1 | Lung cancer arginine auxotrophy | Knockout in NSCLC cell lines, inhibitor treatment |
Urea Transporters in Cancer
UT-B (SLC14A1) is downregulated in melanoma B16 cells, leading to decreased polyamine levels and activation of p53, which suppresses tumor growth. This suggests that urea transporters can influence cancer cell metabolism and may be therapeutic targets. In non-small cell lung cancer, oncogenic KRAS induces arginine auxotrophy, and inhibition of SLC7A1 (an arginine transporter) is a therapeutic vulnerability, highlighting the broader role of solute carriers in cancer.
Kidney Disorders and Osmotic Balance
Mutations in SLC14A1 cause kidney disorders characterized by impaired urine concentration and altered blood pressure. Urea transporters are essential for the urinary concentrating mechanism, and their dysfunction can lead to dehydration and electrolyte imbalances. SLC6A18, a urea antiporter, influences glomerular filtration rate and is implicated in hypertension.
Ocular and Other Tissue Functions
In corneal endothelial cells, urea transporters mediate water and urea transport, which is critical for maintaining corneal transparency and volume regulation. Dysregulation of these transporters may contribute to corneal edema and other ocular pathologies.
From urea transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UT-B loss affect urea transport in erythrocytes? | SLC14A1 knockout mouse |
| How do SLC14A1 mutations alter kidney function? | Knock-in mouse with patient mutation |
| Can UT-B overexpression reduce polyamine levels in melanoma? | Overexpression in B16 melanoma cells |
| What is the role of SLC6A18 in urea secretion? | SLC6A18 knockout rat |
| How does UT-B inhibition affect urine concentration? | UT-B inhibitor (phenylphthalazine) treatment in mice |
| Does tagged UT-B localize differently in polarized cells? | Tagged knock-in of SLC14A1 |
How to Study the urea transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled urea flux assay | Rate of urea transport | Functional characterization of UT-B mutants |
| Cryo-EM | 3D structure of transporter | Understanding urea permeation and inhibitor binding |
| CRISPR knockout | Loss of gene function | Studying physiological role of UT-B in mice |
| Knock-in of point mutations | Effect of specific mutations | Modeling kidney disorders |
| Overexpression | Gain of function | Assessing UT-B role in melanoma |
| Immunofluorescence | Protein localization | Tissue distribution of urea transporters |
| Inhibitor binding assays | IC50 and binding affinity | Screening for UT-B inhibitors |
Transport Assays
Urea transport activity can be measured using radiolabeled urea flux assays in cells or membrane vesicles. These assays quantify the rate of urea uptake or efflux and are used to assess the function of wild-type and mutant transporters. Inhibitor studies with compounds like phenylphthalazines can determine IC50 values and binding kinetics.
Structural Biology
Cryo-electron microscopy and X-ray crystallography have been used to solve the structures of urea transporters, revealing the urea permeation pathway and inhibitor binding sites. These structural insights guide the design of novel inhibitors and help understand disease-causing mutations.
CRISPR-Based Genetic Models
CRISPR/Cas9 technology enables the generation of knockout, knock-in, and overexpression cell lines and animal models to study urea transporter function. For example, SLC14A1 knockout mice have been used to investigate the role of UT-B in urine concentration. Point mutations identified in patients can be introduced into cell lines to assess their impact on transport activity.
Expression and Localization Studies
Immunohistochemistry, immunofluorescence, and Western blotting are used to determine the expression and subcellular localization of urea transporters in tissues and cells. Tagged knock-in models allow real-time tracking of transporter trafficking.
How CRISPR Can Be Used to Study GO:0015204 urea transmembrane transporter activity
Knockout
CRISPR knockout of SLC14A1 or SLC14A2 in cell lines and animal models abolishes urea transport activity, allowing researchers to study the physiological consequences. For example, UT-B knockout mice exhibit impaired urine concentration and altered erythrocyte urea permeability. Knockout models are essential for validating the role of urea transporters in disease.
Point Mutation
Point mutations identified in patients with kidney disorders can be introduced into SLC14A1 using CRISPR prime editing or homology-directed repair. These models help determine whether a specific mutation causes loss or gain of urea transport function. Such studies provide insights into genotype-phenotype correlations.
Knock-in
Knock-in of tagged versions of urea transporters (e.g., GFP or HA tags) enables real-time imaging and biochemical purification. Tagged knock-in models are valuable for studying transporter trafficking and interactions. Additionally, knock-in of human disease mutations into mouse models recapitulates human pathology.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase urea transporter levels in cells, allowing gain-of-function studies. Overexpression of UT-B in melanoma cells reduces polyamine levels and activates p53, demonstrating its tumor-suppressive role. Overexpression models are useful for identifying downstream signaling pathways.
How EDITGENE Supports urea transmembrane transporter activity Research
Researchers studying urea transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in urea transport, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for urea transmembrane transporter activity research.
Frequently Asked Questions About urea transmembrane transporter activity
What is urea transmembrane transporter activity?
Urea transmembrane transporter activity (GO:0015204) is a molecular function that enables the transfer of urea across biological membranes, typically mediated by channel proteins like UT-B.
What genes are involved in urea transmembrane transporter activity?
Key genes include SLC14A1 (UT-B), SLC14A2 (UT-A isoforms), and SLC6A18, which encode proteins that facilitate urea transport.
How is urea transport regulated?
Urea transport is regulated by transcriptional, post-translational, and pharmacological mechanisms, including vasopressin signaling and small-molecule inhibitors.
What diseases are associated with urea transporters?
Mutations in SLC14A1 cause kidney disorders, and UT-B downregulation is linked to melanoma progression.
Can urea transporters be targeted therapeutically?
Yes, small-molecule inhibitors like phenylphthalazines have been developed to inhibit UT-B, and targeting urea transport is being explored in cancer and kidney diseases.
What methods are used to study urea transport?
Common methods include radiolabeled urea flux assays, cryo-EM, CRISPR knockout/knock-in models, and immunofluorescence.
What is the role of UT-B in melanoma?
UT-B downregulation in melanoma cells reduces polyamine levels and activates p53, suppressing tumor growth.
How does SLC6A18 contribute to urea transport?
SLC6A18 functions as a Na-dependent glycine/urea antiporter in the proximal straight tubule, influencing urea secretion and glomerular filtration rate.
Are there animal models for urea transport disorders?
Yes, knockout mice for SLC14A1 and SLC14A2 are available, and knock-in models of patient mutations are being developed.
What is the structural basis of urea transport?
Urea transporters form channels with a central pore that binds urea; structural studies have revealed the permeation pathway and inhibitor binding sites.
Conclusion
Urea transmembrane transporter activity (GO:0015204) is a critical molecular function that governs urea flux across membranes, impacting nitrogen balance, osmotic regulation, and disease. The SLC14A family and related transporters are key players, and their dysfunction is linked to kidney disorders and cancer. Advances in structural biology and CRISPR-based models continue to unravel the mechanisms of urea transport, offering new therapeutic opportunities. Targeting urea transporters holds promise for treating diseases ranging from melanoma to kidney dysfunction.
References
- 1. Gai X et al.. 2024. Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer.. Cancer Res 84(12):1963-1977 PMID: 38502865
- 2. Huang SM et al.. 2024. Structural insights into the mechanisms of urea permeation and distinct inhibition modes of urea transporters.. Nat Commun 15(1):10226 PMID: 39587082
- 4. Mishra S et al.. 2024. Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκB.. Proc Natl Acad Sci U S A 121(31):e2314760121 PMID: 39052834
- 5. Bankir L et al.. 2024. The SLC6A18 Transporter Is Most Likely a Na-Dependent Glycine/Urea Antiporter Responsible for Urea Secretion in the Proximal Straight Tubule: Influence of This Urea Secretion on Glomerular Filtration Rate.. Nephron 148(11-12):796-822 PMID: 38824912
- 6. Li J et al.. 2022. Urea transporter B downregulates polyamines levels in melanoma B16 cells via p53 activation.. Biochim Biophys Acta Mol Cell Res 1869(5):119236 PMID: 35143901
- 7. Ran JH et al.. 2016. Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model.. Acta Pharmacol Sin 37(7):973-83 PMID: 27238209
- 8. Katkova LE et al.. 2025. Transmembrane Transport of Water and Urea in Rat Corneal Endothelial Cells.. Biochemistry (Mosc) 90(10):1366-1375 PMID: 41176795
